Back to Search
BHARATH ARUN, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1235981069Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Decreased TGFbeta signaling and increased COX2 expression in high risk women with increased mammographic breast density.
PMID 19241157·Breast Cancer Res Treat·2010
4-observational
Clinical features associated with a favorable outcome following neoadjuvant chemotherapy in women with localized breast cancer aged 35 years or younger.
PMID 18581139·J Cancer Res Clin Oncol·2009
4-observational
High prevalence of preinvasive lesions adjacent to BRCA1/2-associated breast cancers.
PMID 19174581·Cancer Prev Res (Phila)·2009
8-other
Ductal carcinoma in situ: state of the science and roadmap to advance the field.
PMID 19064970·J Clin Oncol·2009
6-review
Accuracy of the BRCAPRO model among women with bilateral breast cancer.
PMID 19127556·Cancer·2009
8-other
Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation.
PMID 19280625·Cancer·2009
8-other
Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy.
PMID 19172584·Cancer·2009
8-other
Anti-carbohydrate antibodies of normal sera: findings, surprises and challenges.
PMID 19608278·Mol Immunol·2009
8-other
A randomized, phase II, dose-finding study of the pan-ErbB receptor tyrosine-kinase inhibitor CI-1033 in patients with pretreated metastatic breast cancer.
PMID 19294387·Cancer Chemother Pharmacol·2009
3-trial
Long-standing hidradenitis suppurativa treated effectively with metformin.
PMID 19323659·Clin Exp Dermatol·2009
5-case
American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.
PMID 19470930·J Clin Oncol·2009
6-review
Imatinib mesylate (Gleevec) in advanced breast cancer-expressing C-Kit or PDGFR-beta: clinical activity and biological correlations.
PMID 18515258·Ann Oncol·2008
3-trial
Collagen IV levels are elevated in the serum of patients with primary breast cancer compared to healthy volunteers.
PMID 18560403·Br J Cancer·2008
8-other
Phase 3 study comparing the use of docetaxel on an every-3-week versus weekly schedule in the treatment of metastatic breast cancer.
PMID 18300256·Cancer·2008
3-trial
Coordinated prophylactic surgical management for women with hereditary breast-ovarian cancer syndrome.
PMID 18410690·BMC Cancer·2008
8-other
Tannins present in Cichorium intybus enhance glucose uptake and inhibit adipogenesis in 3T3-L1 adipocytes through PTP1B inhibition.
PMID 18534569·Chem Biol Interact·2008
7-preclinical
Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women.
PMID 18026834·Breast Cancer Res Treat·2008
4-observational
Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells.
PMID 18424910·Autophagy·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 374 STOCKHOLM ST
BROOKLYN, NY 11237 - Phone
- (718) 963-7272
Quick Facts
- NPI
- 1235981069
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile